SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D1/A - Tender offer statement.: [Amend]
SEC Accession No. 0000912057-99-004905
Filing Date
1999-11-12
Accepted
1999-11-12 00:00:00
Documents
1
Group Members
PHARMACEUTICAL PARTNERS, L.L.C.PHARMACEUTICAL ROYALTIES, L.L.C.PHARMACEUTICAL ROYALTY INVESTMENTS LTD.PHARMAINVEST LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14D1/A SC 14D1/A 5446
  Complete submission text file 0000912057-99-004905.txt   7743
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Subject) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D1/A | Act: 34 | File No.: 005-34640 | Film No.: 99747217
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PHARMACEUTICAL PARTNERS 70 EAST 55TH STREET 23RD FLOOR NEW YORK NY 10022
Business Address C/O PHARACEUTICAL PARTNERS 70 EAST 55TH ST 23RD FLOOR NEW YORK NY 10022 2127519300
PHARMAINVEST LLC (Filed by) CIK: 0001044732 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231